Structural requirements of (E)-6-benzylidene-4a-methyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one derivatives as novel melanogenesis inhibitors.

Chalcone type compound 1a ((E)-6'-benzylidene-4a'-methyl-4',4a',7',8'-tetrahydro-3'H-spiro[[1,3]dithiolane-2,2'-naphthalen]-5'(6'H)-one) was discovered as an potent inhibitor in melanogenesis. To define its structure-activity relationship, a series of analogs 1b-n, dithiolane truncated 2a-b and ring A removed 3a-e were prepared and evaluated. The electron donating substitution on the phenyl ring (ring C) rather than an electron withdrawing group and dithiolane motif of 1 are needed for the activity enhancement. The scaffold containing both rings A and B associated with α,β-unsaturated system connected to phenyl of 1 was essential for antimelanogenesis.

[1]  Masayuki Yoshikawa,et al.  Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells. , 2009, Bioorganic & medicinal chemistry.

[2]  Shweta,et al.  Prenylated chalcones isolated from Crotalaria genus inhibits in vitro growth of the human malaria parasite Plasmodium falciparum. , 2005, Bioorganic & medicinal chemistry letters.

[3]  Masayuki Yoshikawa,et al.  Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells. , 2010, Bioorganic & medicinal chemistry.

[4]  T. Scanlan,et al.  Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands. , 2004, Bioorganic & medicinal chemistry letters.

[5]  I. Kubo,et al.  2-hydroxy-4-isopropylbenzaldehyde, a potent partial tyrosinase inhibitor. , 2004, Bioorganic & medicinal chemistry letters.

[6]  V. Hearing,et al.  Analysis of mammalian pigmentation at the molecular level. , 1989, Pigment cell research.

[7]  Sang-Hun Jung,et al.  Evaluation of 3,4-dihydroquinazoline-2(1H)-thiones as inhibitors of alpha-MSH-induced melanin production in melanoma B16 cells. , 2010, Bioorganic & medicinal chemistry.

[8]  C. Lee,et al.  Synthetic tyrosyl gallate derivatives as potent melanin formation inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[9]  Takashi Suzuki,et al.  Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. , 2006, Journal of natural products.

[10]  H. Glatt,et al.  Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. , 1999, Biochemical pharmacology.

[11]  N. Davidson,et al.  Anticancer activities of novel chalcone and bis-chalcone derivatives. , 2006, Bioorganic & medicinal chemistry.

[12]  T. Liljefors,et al.  Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis. , 1998, Journal of medicinal chemistry.

[13]  Jiri Gut,et al.  Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. , 2005, Journal of medicinal chemistry.

[14]  J. Vaya,et al.  Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. , 2005, Bioorganic & medicinal chemistry.

[15]  G. Hong,et al.  Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors. , 2007, Bioorganic & medicinal chemistry.

[16]  Z. Nowakowska.  A review of anti-infective and anti-inflammatory chalcones. , 2007, European journal of medicinal chemistry.

[17]  Youngsoo Kim,et al.  Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5. , 2010, European journal of medicinal chemistry.

[18]  Paul Meredith,et al.  Radiative Relaxation Quantum Yields for Synthetic Eumelanin¶ , 2003, Photochemistry and photobiology.

[19]  Sang-Hun Jung,et al.  Structural requirement(s) of N-phenylthioureas and benzaldehyde thiosemicarbazones as inhibitors of melanogenesis in melanoma B 16 cells. , 2010, Bioorganic & medicinal chemistry letters.

[20]  D. Sohn,et al.  Heme oxygenase 1 mediates anti-inflammatory effects of 2',4',6'-tris(methoxymethoxy) chalcone. , 2006, European journal of pharmacology.

[21]  I. Koshima,et al.  Repeated Treatment Protocols for Melasma and Acquired Dermal Melanocytosis , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[22]  Francisco Solano,et al.  Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.

[23]  P. Moeller,et al.  Intramolecular, Reductive Coupling of Bis-α,β-unsaturated Ketones , 1989 .

[24]  E. Berardesca,et al.  Clinical and Instrumental Evaluation of Skin Improvement after Treatment with a New 50% Pyruvic Acid Peel , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[25]  K. Tsujimoto,et al.  Methyl p-coumarate, a melanin formation inhibitor in B16 mouse melanoma cells. , 2004, Bioorganic & medicinal chemistry.

[26]  Sarot Cheenpracha,et al.  Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. , 2006, Bioorganic & medicinal chemistry.

[27]  S. Maruyama,et al.  N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells. , 2009, Bioorganic & medicinal chemistry letters.

[28]  E. Perrier,et al.  Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase. , 2006, Bioorganic & medicinal chemistry letters.

[29]  R. Furlan,et al.  Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi. , 2004, Journal of agricultural and food chemistry.

[30]  J. Y. Lee,et al.  Natural ortho-dihydroxyisoflavone derivatives from aged Korean fermented soybean paste as potent tyrosinase and melanin formation inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[31]  K. Yoshino,et al.  Enzymatic synthesis of arbutin undecylenic acid ester and its inhibitory effect on melanin synthesis. , 2007, Bioorganic & medicinal chemistry letters.

[32]  Hyun Pyo Kim,et al.  Prenylated flavonoids as tyrosinase inhibitors , 2004, Archives of pharmacal research.

[33]  I. Kubo,et al.  Molecular design of antibrowning agents. , 2000, Journal of agricultural and food chemistry.

[34]  Marc Criton,et al.  Analogues of N-hydroxy-N'-phenylthiourea and N-hydroxy-N'-phenylurea as inhibitors of tyrosinase and melanin formation. , 2008, Bioorganic & medicinal chemistry letters.